BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34877225)

  • 1. Stage Migration in Cervical Cancer Using the FIGO 2018 Staging System: A Retrospective Survival Analysis Using a Single-Institution Patient Cohort.
    Vengaloor Thomas T; Reddy KK; Gandhi S; Nittala MR; Abraham A; Robinson W; Ridgway M; Packianathan S; Vijayakumar S
    Cureus; 2021 Nov; 13(11):e19289. PubMed ID: 34877225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
    Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
    Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
    Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of the presence of pelvic and/or para-aortic lymph node metastases in cervical cancer patients; the influence of the new FIGO classification (stage IIIC).
    van Kol KGG; Ebisch RMF; van der Aa M; Wenzel HB; Piek JMJ; Bekkers RLM
    Gynecol Oncol; 2023 Apr; 171():9-14. PubMed ID: 36804623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
    Ayhan A; Aslan K; Bulut AN; Akilli H; Öz M; Haberal A; Meydanli MM
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():209-214. PubMed ID: 31325847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-classification of uterine cervical cancer cases treated with radical hysterectomy based on the 2018 FIGO staging system.
    Osaku D; Komatsu H; Okawa M; Iida Y; Sato S; Oishi T; Harada T
    Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1054-1058. PubMed ID: 34794737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the 2018 FIGO cervical cancer staging system.
    Matsuo K; Machida H; Mandelbaum RS; Konishi I; Mikami M
    Gynecol Oncol; 2019 Jan; 152(1):87-93. PubMed ID: 30389105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.
    Yang E; Huang S; Ran X; Huang Y; Li Z
    BMC Cancer; 2021 Feb; 21(1):203. PubMed ID: 33639874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification.
    Holm J; Gerke O; Vilstrup MH; Spasojevic D; Sponholtz SE; Jochumsen KM; Thomassen A; Hildebrandt MG; Jensen PT
    Gynecol Oncol; 2022 Nov; 167(2):152-158. PubMed ID: 36182533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing survival outcomes for cervical cancer based on the 2014 and 2018 International Federation of Gynecology and Obstetrics staging systems.
    Shin W; Ham TY; Park YR; Lim MC; Won YJ
    Sci Rep; 2021 Mar; 11(1):6988. PubMed ID: 33772044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the 2018 FIGO staging system for cervical cancer patients with surgical risk factors.
    Yan DD; Tang Q; Chen JH; Tu YQ; Lv XJ
    Cancer Manag Res; 2019; 11():5473-5480. PubMed ID: 31354353
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
    Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
    Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer.
    Halle MK; Bozickovic O; Forsse D; Wagner-Larsen KS; Gold RM; Lura NG; Woie K; Bertelsen BI; Haldorsen IS; Krakstad C
    Gynecol Oncol; 2024 Feb; 181():110-117. PubMed ID: 38150835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the FIGO 2018 staging system of cervical cancer: Retrospective analysis of FIGO 2009 stage IB1 cervical cancer with tumor under 2 cm.
    Takahashi M; Sakai K; Iwasa N; Wada M; Hino M; Kurahashi T; Ueno M; Nakagawa H
    J Obstet Gynaecol Res; 2021 May; 47(5):1871-1877. PubMed ID: 33611822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current FIGO Staging for Carcinoma of the Cervix Uteri and Treatment of Particular Stages.
    Sehnal B; Kmoníčková E; Sláma J; Tomancová V; Zikán M
    Klin Onkol; 2019; 32(3):224-231. PubMed ID: 31216857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do clinical characteristics and metabolic markers detected on positron emission tomography/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?
    Akkas BE; Demirel BB; Dizman A; Vural GU
    Ann Nucl Med; 2013 Oct; 27(8):756-63. PubMed ID: 23793926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the New FIGO Classification for Cervical Cancer on Patient Survival: A Retrospective Analysis of 265 Histologically Confirmed Cases with FIGO Stages IA to IIB.
    de Gregorio A; Widschwendter P; Ebner F; Friedl TWP; Huober J; Janni W; de Gregorio N
    Oncology; 2020; 98(2):91-97. PubMed ID: 31593942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.
    Chen X; Duan H; Liu P; Lin L; Ni Y; Li D; Dai E; Zhan X; Li P; Huo Z; Bin X; Lang J; Chen C
    Ann Transl Med; 2022 Jan; 10(2):121. PubMed ID: 35282114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FIGO Classification 2018: Validation Study in Patients With Locally Advanced Cervix Cancer Treated With Chemoradiation.
    Raut A; Chopra S; Mittal P; Patil G; Mahantshetty U; Gurram L; Swamidas J; Ghosh J; Gulia S; Popat P; Deodhar K; Maheshwari A; Gupta S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1248-1256. PubMed ID: 32681859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.